ViaDerma Inc (EM) (VDRM)

He has nothing to sell but more lies

Face Book CVS Walgreens It's all laughable

It has become apparent to me that IR knows nothing (I know others have said this before). Not sure why that is. I can only assume that they also do not communicate with Otiko very often. Who knows, maybe their not getting paid. Maybe there is simply nothing to report.

I would love to see it removed from my stock list as well. Every day I see a big red negative number and it's like getting hit on the top of the head with a stupid stick for falling for Otiko's bullshit to begin with. At this point, we could easily be asking the same questions next year at this time. I just wish he would man-up and have the professional courtesy to come out and tell us it's over so I can put it behind me.

Otiko, if you or any of your supposed new-hires are reading this thread....WTF ARE YOU DOING????? IT'S BEEN OVER A YEAR ON THE EXPERT MARKET. DO YOU UNDERSTAND THAT WE CAN'T TRADE THE STOCK??? EFFECTIVELY WE HAVE ALL LOST OUR MONEY!!!!! DO YOU GIVE A SHIT AT ALL????

Yep, more bs responses. The fact that Otiko isn't manning up and communicating what is happening is very disturbing and why these small companies are a crapshoot at best. The leadership drives companies forward, and it's clear as day that otiko is not a leader in any way, shape or form. I've seen the same shit from a bunch of other tiny companies over the years. These companies should never be allowed to go public until the president/CEO can demonstrate competency in running the company.

I just want to get it from showing up in my list of stocks each day.

LOL.THE GUY THAT WAS TALKING TO RICHIE.AND ALL WAS GOOD.AND FILINGS WOULD COME BACK IN JANUARY.LMAO

DeerBalls

Re: None

Saturday, December 27, 2025 8:09:41 PM

Post#
77160
of 77468
VDRM will be back, better than ever.....

ATTENTION TO ALL SHAREHOLDERS.IF YOU EVER SEE OTIKO AS A CEO ON A NEW COMPANY THAT TRADES PLEASE LET ME KNOW IMMEDIATELY.HIS NAME IS AS GOOD AS $HIT.HE IS FD FOR EVER RUNNING ANOTHER PUBLIC COMPANY.

THIS ANSWER YOU RECEIVED SAYS ALL YOU NEED TO KNOW.THIS THING WILL NEVER COME BACK TO TRADING IMO.
Here is the response I received on May 7th: I am really sorry I dont have anything new to tell you just yet. Unfortunately it is not as easy as just filing the missing statements because of the changes to the OTC with the introduction of the OTCIQ. Still working on a resolution.

On May 8th, I then sent the following email. To date I have not received a response:

Thank you for the response. I appreciate the acknowledgment and understand that the OTCIQ transition has added complexity beyond simply filing missing statements.

From a shareholder perspective, the continuing operational activity; including the updated website, VitaStem/SkinPass promotion, hiring efforts, and discussion of expansion opportunities, etc. suggests that the company continues to build the business despite the ongoing Expert Market situation. Because of that, many shareholders remain hopeful that the company ultimately intends to restore tradability and emerge in a stronger position.

My own view has been that management may be prioritizing the development of recurring revenues, potential retail distribution opportunities, stronger financial positioning, outside investment, and audited financials before taking steps toward returning to a fully tradable public status. Of course, I understand that this is only my interpretation and that the company may not yet be able to comment on specific plans or timing.

At this stage, however, the largest source of shareholder frustration appears to be the limited communication rather than the delay itself. Even occasional high-level updates acknowledging progress, challenges, or general intentions would likely go a long way toward maintaining shareholder confidence during this process.

Thank you again for your time and consideration.

On May 6th, I sent the following email to Rich:

I wanted to follow up on my previous email, as I did not receive a response.

Many long-term shareholders are becoming increasingly discouraged by the continued lack of communication regarding the company’s status and plans for resuming public trading. As the one-year anniversary of VDRM entering the Expert Market approaches, the silence has unfortunately created significant uncertainty among investors.

At the same time, shareholders continue to see signs that the company remains operational and active, including the updated website, ongoing product promotion, hiring efforts, and prior public comments regarding expansion opportunities. This visible business activity versus the absence of shareholder updates has made many investors unsure how to interpret the company’s direction moving forward.

I fully understand that management may not yet be in a position to disclose certain developments. However, even a general update or brief reassurance from Dr. Otiko or Investor Relations regarding the company’s intentions and progress would mean a great deal to shareholders who have remained supportive during this difficult period.

Thank you again for your time and consideration.

Here is the response I received on May 7th: I am really sorry I dont have anything new to tell you just yet. Unfortunately it is not as easy as just filing the missing statements because of the changes to the OTC with the introduction of the OTCIQ. Still working on a resolution.

IR part timers, Rich, is not even answering emails or calls anymore. What a complete disaster of a company through and through. If Otiko did scam us, I hope he rots in hell...soon. I'm holding out hope he's just a completely incompetent pos.

Come on Dr. Come up with another scam so we can bring this piece of $hit back to life….. has anyone heard anything from these? A holes do we still have a pulse?

TODAY IS BEEN MORE THAN A YEAR THAT THE SCAMBAG OTIKO PUT THE SHAREHOLDERS IN THE DARK FOR GOOD.BY ALLOWING THE POS COMPANY TO GO TO EXPERT MARKET.AND SHAFT ALL SHARE HOLDERS WITH SOME LOSING 6 FIGURE $$$
GOD IS WATCHING YOU OTIKO.VERY CLOSELY.NO ONE GETS AWAY LITTLE MAN.FOR DOING BAD TO PEOPLE.

Market Change 05/16/2025 VDRM Market change from Pink Limited to Expert Market

How do U run out when U never had it?

Dr. & family needed the $$ 4 a vacation

Website says sold out… OK SO WHERE’S THE MONEY? .. it must of been deposited in the same bank as the Nigerian sale

Maybe Dr. dirtbag can sell holy water and bring us back from the dead

Maybe Dubai bought it all 🤣

Looks like they’re sold out. Either they sold a ton or they haven’t made any yet???

Vitastem Sales Website:
https://store.getvitastem.com/

It appears it started around April 1.....

OTIKO SHAFTED MAJORLY ALL THE SHAREHOLDERS OF VDRM.I BELIEVE THERE ARE SOME GUYS HERE,THAT HAVE INVESTED 6 FIGURES IN THIS THING.

This is a factual statement

Dig into red flags in management behavior?

Really? These were all pointed out several times along the way....yall just chose to ignore and ridicule those pointing them out...

Wow somebody hit 10 and 12 appear on. The bid

Think they sold 4 cheap?

So what it could be 10 cents and I still can’t sell or buy a share… Dr Dirtbag should be ashamed of himself … his day will come ….

no respect should have never happened

10k on the bid at .0011

I like your thinking and you could be right. For now this is a totally dead, but not gone, investment.

While super frustrating, I would rather be illiquid for another 24 months and have them re-enter the market as a strong going concern with healthy debt levels, vs re-listing with the train wreck financials from the last update. I think we stand to make more by waiting, if in fact they’re able to get their act together. And I’ve got 70K tied up here so believe me I’m not happy about it. But I’ve come to terms with this having greater potential by getting stronger prior to relisting than rushing it. And for my emotional and financial health, my 70K is dead money at this point. If it happens to relist, fantastic. But I’m assuming the worst for now while hoping for better days in the future.

My take is that Otiko is in no hurry to get uplisted. If Otiko truly believes that Vitastem/SkinPass can scale to market, retail distribution is real, Africa expansion is real, funding is material, and that revenues could become substantial, then remaining public has potentially enormous upside for him personally because of the large number of shares he holds. Why would he pass on the opportunity to potentially make hundreds of millions of dollars? That being the case, one would think that restoring tradability would be a very high priority. While Otiko might be in no hurry to get uplisted, my theory is that he is waiting for recurring revenues, major retail rollout, stronger balance sheet, outside capital investment and audited financial statements. All of that could be baked into a reorganization of sorts that allows VDRM to emerge from the Expert Market in a much better positon. Yeah I know it's wishful thinking. If that is the case, we could be looking at another 6 to 12 to 18 months or longer.

Given that, until there is something to report, there is nothing to report. See you all in 6 months.

From ChatGPT about VDRM:

Here’s the reality of what’s going on with ViaDerma, Inc. (VDRM) — and I’ll be direct, because this situation is pretty common in microcap/OTC names.

---

# 🧭 1. What actually happened (delisting / “under review”)

VDRM hasn’t been “delisted” in the traditional sense (like being removed from NASDAQ). Instead:

* It has been moved to the **OTC Expert Market** ([GuruFocus][1])
* This typically happens when a company:

* **Fails to stay current with financial filings**
* Falls out of compliance with OTC reporting rules

👉 Key consequence:

* Shares become **extremely illiquid**
* Retail investors often **can’t buy** (only limited selling)
* Public information becomes **very limited**

This is why it *feels* like a delisting — but technically it’s a downgrade to a restricted market tier.

---

# 📊 2. Why they were pushed there

The biggest issue is straightforward:

* The company has had **overdue annual and quarterly reports** ([GuruFocus][1])
* There are **no consistent SEC filings available** ([Nasdaq][2])

That’s a major red flag in public markets.

Even the company itself admitted:

* They are **working to complete overdue reports**
* They are trying to get back into compliance ([GuruFocus][1])

---

# 🧪 3. Is the company dead?

Not necessarily — but it’s not in good shape either.

From their own updates:

* They claim to be **“fully operational”** ([GuruFocus][1])
* They’re still talking about:

* International shipments (e.g., Nigeria orders)
* Expansion (Dubai, India, etc.) ([GlobeNewswire][3])

BUT:

* Market cap is ~**$500K** ([Yahoo Finance][4])
* Revenue is extremely small relative to losses ([Simply Wall St][5])
* Stock is down ~**-97%+ long term** ([Simply Wall St][5])

👉 Translation:
This is **deep microcap / survival-mode territory**.

---

# ⚖️ 4. Why the CEO is quiet (this part matters most)

You asked a very sharp question here.

There are **3 possible reasons** — and honestly, it’s usually a mix:

### (A) Legal / regulatory restrictions

When a company is:

* Not current with filings
* On Expert Market

They often:

* **Limit public statements**
* Avoid forward-looking disclosures

Also:

* They **can’t freely promote the stock** without current filings (SEC risk)

👉 So yes — there *can* be legal pressure to stay quiet.

---

### (B) Structural limitation of the Expert Market

Companies on Expert Market:

* **Can’t post filings on OTCMarkets** directly ([BioSpace][6])
* Must use alternative channels (like their own website)

This reduces visibility and communication flow.

---

### (C) The uncomfortable truth (common in OTC)

A lot of companies in this situation:

* Go **long periods without communication**
* Prioritize survival over shareholder updates
* Sometimes simply **don’t have meaningful progress to report**

👉 In OTC land, this is *very common behavior*, not necessarily illegal.

---

# 🚨 5. Is the CEO failing his duty?

Here’s the honest answer:

* **Legally:**

* He is *not required* to constantly update shareholders like a big public company
* Especially if filings are not current

* **From an investor standpoint:**

* Lack of communication + missed filings = **poor governance**

👉 So:

* Not necessarily illegal
* But definitely **a red flag for investors**

---

# 🧠 6. What to watch going forward

If you’re holding VDRM, the only things that matter now:

### ✅ Positive signals

* Filing **current financials**
* Moving off Expert Market (back to OTC Pink Current)
* Verified revenue growth (not just PRs)

### 🚩 Negative signals

* Continued silence
* No filings for extended periods
* More “PR-style” updates without hard numbers

---

# 🧾 Bottom line

* VDRM is **not fully dead**, but it’s in a **very weak regulatory and financial position**
* The “delisting” you’re seeing is really:
? **Loss of reporting compliance ? Expert Market downgrade**
* CEO silence is:
? **Partly legal / structural**
? **Partly typical OTC behavior**
? **And possibly lack of progress**

---

If you want, I can dig into **share structure, dilution history, or red flags in management behavior** — that’s usually where the real story shows up with stocks like this.

[1]: https://www.gurufocus.com/news/2907480/viaderma-inc-confirms-ongoing-operations-and-commitment-to-regulatory-compliance-vdrm-stock-news?utm_source=chatgpt.com "ViaDerma, Inc. Confirms Ongoing Operations and ..."
[2]: https://www.nasdaq.com/market-activity/stocks/vdrm/sec-filings?utm_source=chatgpt.com "ViaDerma Inc (VDRM) SEC Filings"
[3]: https://www.globenewswire.com/search/organization/ViaDerma%2520Licensing?utm_source=chatgpt.com "Latest News and Press Releases"
[4]: https://finance.yahoo.com/quote/VDRM/?utm_source=chatgpt.com "ViaDerma, Inc. (VDRM) Stock Price, News, Quote & History"
[5]: https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-vdrm/viaderma?utm_source=chatgpt.com "ViaDerma (OTCPK:VDRM) - Stock Analysis"
[6]: https://www.biospace.com/press-releases/viaderma-announces-posting-of-annual-report-and-ongoing-evaluation-of-public-status-in-response-to-market-changes?utm_source=chatgpt.com "ViaDerma Announces Posting of Annual Report and ..."

For what its worth, I asked AI to analize the job posting in light of other factors:

On one hand, companies that are truly dead or preparing to disappear usually do not:

* hire junior analysts,
* invest in operational infrastructure,
* maintain ecommerce/web operations,
* build dashboards and reporting systems,
* coordinate inventory/distribution,
* or continue external marketing and podcast appearances.

The posting suggests ViaDerma is still functioning operationally and trying to build internal business processes. The emphasis on PowerBI, Tableau, SQL, Asana, QuickBooks, inventory management, and KPI tracking looks like a company attempting to professionalize operations rather than simply abandon the business.

There are also still visible signs of life publicly:

* active corporate website,
* ongoing SkinPass/VitaStem promotion,
* podcast appearances by management,
* international distribution messaging,
* references to donations/NGO initiatives,
* and public statements in 2025 about continuing operations and working toward compliance. ([InvestorsHub][1])

However — and this is the important distinction — operational activity is not the same thing as shareholder-friendly execution. That is where the bearish case becomes stronger. The major issue is that nearly all observable progress has been:

* commercial,
* promotional,
* operational,
* or aspirational,

while the actual securities/compliance side has remained largely unresolved.

The biggest red flags remain:

1. Prolonged Expert Market status
A year on the Expert Market is extremely damaging for credibility. The longer a company remains there, the harder it becomes to maintain shareholder confidence because:

* liquidity disappears,
* retail participation collapses,
* transparency declines,
* and management communication often deteriorates.

The silence itself becomes part of the problem.

2. Lack of concrete uplisting milestones
I could not find evidence that ViaDerma:

* became current with OTC reporting,
* entered OTCID,
* restored public quotation,
* secured audited filings sufficient for higher-tier OTC status,
* or provided a definitive roadmap with dates. ([InvestorsHub][1])

That absence matters more than podcasts or hiring announcements.

3. “Evaluating strategic options related to its public status”. That language from 2025 is subtle but important.

Companies use wording like that when:

* considering restructuring,
* reducing reporting burdens,
* merging,
* recapitalizing,
* or potentially going dark/private.

It does not prove they are going private — but it absolutely opens the door to the possibility.

4. Chronic overpromising history
You mentioned this yourself, and that’s probably the core issue.

ViaDerma has historically produced:

* many announcements,
* large opportunity narratives,
* international expansion stories,
* licensing/distribution updates,
* future revenue potential,
without corresponding shareholder value realization.

Eventually investors stop reacting to announcements and start demanding audited execution. That appears to be where sentiment is now. My overall assessment:

I do not think ViaDerma currently looks like a completely abandoned shell.

It appears more likely that:

* the business itself is still alive,
* management is still trying to commercialize products,
* and some operational growth efforts are real.

But I also do not think there is strong evidence yet of a disciplined, shareholder-focused path back to normal market status. Right now the company looks caught between two realities:

Operationally alive but Capital-markets dysfunctional. That is a dangerous middle ground for public shareholders. As for your fear about going private:

* I do not see hard evidence that this is imminent.
* But I also cannot dismiss the concern because management’s communication pattern and “strategic options” language leave the possibility open.

The key thing I would watch now is not more podcasts or hiring posts. I would watch for one of these:

* audited/current filings,
* OTC compliance milestones,
* restored quotation capability,
* institutional financing,
* transparent shareholder communication,
* or a definitive restructuring announcement.

Without one of those, operational “signs of life” may continue while shareholders remain trapped in illiquidity.

And psychologically, that’s probably why the silence feels so deafening: investors can see activity, but not progress on the thing that actually matters to shareholders — market accessibility and trust.

Read below V V V Walgreens and CVS are undergoing massive, long-term restructuring, closing thousands of stores due to overexpansion, low reimbursement rates from insurers, high theft, and competition from online retailers. Walgreens plans to close 1,200 stores and CVS is wrapping up a 900-store closure plan, causing "pharmacy deserts" and shifting to smaller, health-focused, or online models.

I'm sure hundreds will apply for that hoax

Just saw this on the website:
Junior Business Analysts

ViaDerma, Inc. in Las Vegas, Nevada is looking for Junior Business Analysts. Qualified candidates will be responsible for conducting market research to identify trends, opportunities, and competitive landscape within the topical antibiotic market;

If only there were signs earlier on

No time Hard day at the water park with famliy

Not a single word to or about share holders.

He just wants to save the world.

Yes Dr. Dirtbag stole our money and ran and that special place in hell is waiting for him hopefully he don’t keep them waiting long

April is gone. May 15th will mark the one-year anniversary of being relegated to the Expert Market....so we got that going for us.

I assume that if anyone has heard anything, they would've reported it. Anyone??

Ahh, thanks for the clarification on that one!!

Markus,

I just wanted to clarify. The Annual Report I referred to is the Nevada corporate Annual Report, not the Annual Financial Report (or the Quarterly reports) that are MIA.

Thanks for that information. I guess it's a start and better news than we've heard in a long time. Would have been nice for the company to distribute this type of news but I think Rich is extremely part time for the company.

For what its worth, I just received notice from Nevada that VDRM filed its annual report on time. All that really means is that VDRM is considered in good standing in Nevada (its state of incorporation).

Emailed IR. No response. No surprise.

Thanks FT

I recently asked Chatgpt about VDRM. Here's what it spit out (take it with a grain of salt):

I’m checking the company’s recent public footprint and whether there’s any evidence of a real path off Expert Market versus just operating updates. I’ll also look for signs that would support or contradict a “go dark / private” theory.

I found one key public clue already: in July 2025 the company said it was evaluating its “public status,” which makes the “go dark / private” idea worth taking seriously. I’m checking whether that was just vague language or part of a concrete path.

Based on what I could verify publicly, I’d separate operational momentum from capital-markets progress:

Operationally, yes — there are real signs of activity. ViaDerma’s current web presence is much more built out than before, with a live consumer store for VitaStem, a fuller corporate site, SkinPass-focused science/technology pages, and recent promotional activity around SkinPass, including a February 26, 2026 podcast appearance by Christopher Otiko. There is also a recent company blog post about a 10,000-unit VitaStem donation to Ukraine. So your point that they have hired people, modernized the site, built ecommerce, and kept promoting SkinPass is directionally supported by what’s public.

But the market-access side looks much weaker. The two clearest official company statements I found after the Expert Market move were the June 4, 2025 release saying it was still operating while working on overdue annual and quarterly reports, and the July 16, 2025 release saying it posted its 2024 annual report on its website and was evaluating “all strategic options related to its public status,” including in light of OTCID. I did not find a later public announcement showing that it became current, entered OTCID, or restored normal quotation.

Bullish interpretation: management may be trying to keep the business alive first — build product, channels, partnerships, and brand — before spending the money and effort needed to fix the public-company side. The new site, store, podcasting, and humanitarian/commercial messaging all fit that story.

Bearish interpretation: these are mostly commercial/PR signals, not securities-compliance signals. To get off Expert Market, what matters is current disclosure and quotation eligibility, and I’m not seeing public evidence of that step being completed. OTCID replaced Pink Current in July 2025 and requires ongoing disclosure/current information; companies that do not comply remain in limited or expert-style tiers.

On your specific theory — “Maybe he plans to go dark and take the company private?” — I think the answer is:

Possible in theory, but not proven by what I found. The strongest fact in favor of that theory is the company’s own July 16, 2025 language that it was evaluating strategic options related to its “public status.”

What argues against a fully formed going-private plan is that I did not find public evidence of the usual formal markers you’d expect for a real going-private transaction. SEC rules for affiliate-led going-private deals normally involve a Schedule 13E-3 process. I did not find VDRM-specific public search hits for that kind of filing, a tender offer, a merger announcement, or a deregistration filing in the searches I ran. That does not prove none exist, but it means I do not see public confirmation of a formal take-private process right now.

One additional yellow flag worth noting: the 2025 SkinPass-related patent that the company highlights is listed on Google Patents with inventors Christopher Ayo Otiko and David R. Pozek, and Google Patents shows the assignee as “Individual,” while also warning that assignee data may be inaccurate. I would treat that as a verify-this-carefully item, not as proof of wrongdoing, but it is the kind of asset-ownership detail shareholders should want clarified.

My bottom line: Yes, there is credible evidence the business is still doing things operationally. No, I do not see comparable public evidence yet that the company has made real progress toward restoring normal trading. “Going dark / private” is a plausible interpretation of the July 2025 language, but still speculative. I found no formal public filing trail that would let me say that is actually underway.

What I’d watch next is very simple: a real current-information package, OTCID eligibility, a market maker re-engaging quotation, and explicit clarification on who owns the core SkinPass IP. Without those, the website upgrades and trade-show/podcast activity are encouraging operationally but not enough to solve the shareholder liquidity problem.

😂 😂 😂 😂 😂 checkmate 😂 😂 😂 😂 😂

I refuse to fuel your paranoia